Allurion Balloon sales suspended in France; device withdrawn pending remediation plan

ALLURION TECHNOLOGIES, INC.

French regulator ANSM suspended sales; Allurion withdrawing device from French market.
Company cites 20 peer-reviewed articles and 150,000+ patients treated to support safety profile.
Complication rates in line with published literature and lower than other weight loss products.
Allurion cooperating with ANSM on remediation plan for advertising, follow-up, and training.
Company disagrees with decision but seeks path to resume commercialization in France.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.